Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
FDA advisory committee
Pharma
Travere's bid to gain new approval for Filspari hits FDA hitch
After asking for additional information on the drug's clinical benefit a few weeks ago, the FDA has delayed its decision on Filspari to treat FSGS.
Kevin Dunleavy
Jan 14, 2026 11:22am
CDC documents reveal RFK Jr.'s 7 new ACIP nominees: reports
Sep 4, 2025 11:55am
RFK Jr. critic Paul Offit blocked from FDA vaccine panel
Sep 3, 2025 10:44am
Amgen's ChemoCentryx prevails in investor lawsuit
Aug 19, 2025 10:13am
Moderna, Otsuka-Lundbeck, Pfizer-3SBio—Fierce Pharma Asia
Jul 25, 2025 9:46am
FDA advisors overwhelmingly reject Lundbeck, Otsuka's PTSD drug
Jul 21, 2025 11:34am
